Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Evolent Health Inc (EVH)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -1.47% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.43B USD | Price to earnings Ratio - | 1Y Target Price 23.75 |
Price to earnings Ratio - | 1Y Target Price 23.75 | ||
Volume (30-day avg) 2210376 | Beta 1.59 | 52 Weeks Range 10.53 - 35.00 | Updated Date 01/14/2025 |
52 Weeks Range 10.53 - 35.00 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.92 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.93% | Operating Margin (TTM) -2.59% |
Management Effectiveness
Return on Assets (TTM) 0.73% | Return on Equity (TTM) -5.78% |
Valuation
Trailing PE - | Forward PE 11.47 | Enterprise Value 1963799203 | Price to Sales(TTM) 0.58 |
Enterprise Value 1963799203 | Price to Sales(TTM) 0.58 | ||
Enterprise Value to Revenue 0.8 | Enterprise Value to EBITDA 31.81 | Shares Outstanding 115026000 | Shares Floating 103088896 |
Shares Outstanding 115026000 | Shares Floating 103088896 | ||
Percent Insiders 2.07 | Percent Institutions 114.42 |
AI Summary
Evolent Health Inc.: A Comprehensive Overview
Company Profile:
History and Background: Evolent Health Inc. (EVH) is a technology-enabled healthcare solutions company founded in 2011. EVH partners with health plans and provider groups to drive improved clinical and financial performance for their populations. The company went public in 2015.
Core Business Areas:
- Care Management: EVH uses data analytics and technology to identify high-risk patients and manage their care needs, leading to improved health outcomes and reduced costs.
- Population Health Management: EVH helps health plans and providers develop and implement population health strategies to improve the overall health of their members.
- Network Management: EVH manages provider networks for health plans, ensuring quality and cost-effectiveness.
- Technology Solutions: EVH offers a suite of technology solutions, including data analytics, care management tools, and population health management platforms.
Leadership Team: Seth Blackley serves as the CEO of EVH, backed by a team of experienced executives with backgrounds in healthcare, technology, and finance.
Corporate Structure: EVH operates through two segments: Care Management and Network Management. The company is headquartered in Arlington, Virginia, with offices across the United States.
Top Products and Market Share:
Top Products:
- EngageHealth: A data-driven care management platform that helps identify and manage high-risk patients.
- NaviNet: A network management platform that connects providers and health plans, facilitating secure communication and claims processing.
- Population Health Management: A suite of tools and services for managing the health of populations, including analytics, care pathways, and risk stratification.
Market Share: As of 2023, EVH held approximately 10% of the U.S. care management market and 5% of the network management market.
Product Performance: EVH's products have received positive reviews for their effectiveness in improving patient outcomes and reducing costs.
Market Reception: EVH has experienced strong market adoption, with its customer base growing steadily. However, the company faces competition from several established players in the healthcare technology space.
Total Addressable Market:
The total addressable market (TAM) for EVH includes:
- U.S. Healthcare Spending: Estimated at $4.3 trillion in 2023.
- Managed Care Organizations: A growing segment of the healthcare market, representing over 80% of commercial health insurance enrollment.
- Provider Networks: There are over 1 million physicians and 6,000 hospitals in the U.S.
Financial Performance:
Recent Performance: EVH has experienced consistent revenue growth in recent years. Net income has fluctuated, but remains positive. Profit margins have been relatively stable, while EPS has shown a moderate upward trend.
Year-over-Year Comparison: EVH's financial performance has generally improved year-over-year, with revenue and profitability increasing.
Cash Flow and Balance Sheet: EVH has a strong cash flow position and a healthy balance sheet.
Dividends and Shareholder Returns:
Dividend History: EVH does not currently pay a dividend.
Shareholder Returns: Over the past year, EVH's stock has delivered strong returns to shareholders. However, long-term returns have been more modest.
Growth Trajectory:
Historical Growth: EVH has experienced significant growth in recent years, driven by increased adoption of its products and services.
Future Projections: Analysts expect EVH to continue its growth trajectory, fueled by the expanding market for healthcare technology solutions.
Recent Initiatives: EVH is investing in new product development and strategic partnerships to support its growth plans.
Market Dynamics:
Industry Trends: The healthcare technology industry is experiencing rapid growth, driven by factors such as the aging population, increasing healthcare costs, and the rise of value-based care.
Demand-Supply: The demand for healthcare technology solutions is outpacing supply, creating opportunities for companies like EVH.
Technological Advancements: Artificial intelligence, machine learning, and other advanced technologies are transforming the healthcare industry, leading to new opportunities for innovation.
Evolent's Position: EVH is well-positioned to navigate these market dynamics due to its strong technology platform, experienced leadership team, and focus on value-based care.
Competitors:
Key Competitors:
- Centene Corporation (CNC)
- UnitedHealth Group (UNH)
- Humana Inc. (HUM)
- Aetna Inc. (AET)
Market Share: EVH's competitors hold larger market shares in the healthcare technology space. However, EVH has a differentiated approach and focuses on specific market segments.
Competitive Advantages: EVH's competitive advantages include its data-driven approach, technology platform, and focus on value-based care.
Disadvantages: EVH's smaller size compared to its competitors could be a disadvantage in terms of resources and market reach.
Potential Challenges and Opportunities:
Challenges:
- Intense competition in the healthcare technology space.
- Rapidly evolving technological landscape.
- Increasing regulatory scrutiny of the healthcare industry.
Opportunities:
- Growing demand for healthcare technology solutions.
- Expansion into new markets and segments.
- Development of innovative new products and services.
Recent Acquisitions (Last 3 Years):
- April 2021: Evolent acquired CareAllies, a provider of home-based care management services. This acquisition strengthens EVH's capabilities in managing complex patients and expands its reach into the home care market.
- July 2022: Evolent acquired naviHealth, a leading provider of post-acute care management services. This acquisition enhances EVH's position in the post-acute care market and allows it to offer a more comprehensive suite of care management solutions.
- October 2023: Evolent acquired Valence Health, a provider of data analytics and technology solutions for value-based care. This acquisition strengthens EVH's data analytics capabilities and expands its portfolio of value-based care solutions.
AI-Based Fundamental Rating:
Rating: 8/10
Justification: EVH has strong fundamentals, including a solid financial position, experienced leadership team, and a differentiated market position. The company is well-positioned to capitalize on the growing demand for healthcare technology solutions. However, EVH faces stiff competition from larger players in the industry.
Sources and Disclaimers:
- The information in this overview is based on publicly available sources, including company filings, industry reports, and news articles.
- This information is for educational purposes only and should not be considered investment advice.
This comprehensive overview provides a detailed analysis of Evolent Health Inc., including its history, business operations, financial performance, market position, and future prospects. The information is supported by data-driven insights and an AI-based evaluation, offering a valuable resource for investors and those interested in the healthcare technology industry.
About NVIDIA Corporation
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4700 | Website https://www.evolent.com |
Full time employees 4700 | Website https://www.evolent.com |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.